Trial intelligence / Profile preview

Sotrastaurin vs Tacrolimus in Kidney Transplant

NCT00492869Phase 2Completed

Sponsor
Novartis
Start
Jan 2007
Primary completion
May 2008
Modality
Small Molecules
Countries
7
01

Overview

A Phase 2 trial of sotrastaurin in kidney transplant rejection, sponsored by Novartis. Started Jan 2007; status: completed.

02

Drugs

sotrastaurin
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00492869.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00492869.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call